With the impact and cost of long COVID becoming ever more apparent, ongoing pandemic responses will need to be about protecting quality of life as much as saving lives.
Specialty prescription drugs are responsible for countless medical miracles, but their high price tag is the main reason health care costs are out of control.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can’t afford all of them. How then are decisions about which drugs to subsidise made?